SYK - Stryker Corporation
A medical technology company specializing in orthopedic implants, surgical equipment, and neurotechnology — a steady compounder in the healthcare devices space.
Finlify Score
34.1 / 100
Data Quality
FULL
Penalty
0.0
Sector
Health Care
Close Price
$275.56
+2.06%
52W Range
$269.64 - $392.95
Market Cap
$124.2B
+2.1%Compared to previous day
2026 Q1 Revenue
$6.0B
-16.1%Changes from last reporting quarter
2026 Q1 EPS
$1.00
Diluted shares
Analyst Rating
34 analysts in latest ratings feed
RSI
19.3
<40 oversold
2Y Range Position
6%
-32.2% from high / +3.2% from low
Beta
0.82
Relative to market benchmark
MACD
-6.18
MACD line -14.27 / signal line -8.08
Fundamental Trend
Growth 14.2Financial Health
Quality 61.1Data Quality
FULLValuation Reference
Price Chart
Close price, two-year source window
Finlify Score
AVOID34.1 / 100
Score History
Finlify Score and component trend
Financial Statements
Calendar year view. Figures are estimates only. For official figures, refer to the company website.
| 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | |
|---|---|---|---|---|
| Revenue | $6.0B-16.1% | $7.2B+18.4% | $6.1B+0.6% | $6.0B+2.7% |
| Gross Profit | $3.8B-17.7% | $4.6B+20.1% | $3.9B+0.3% | $3.8B+2.6% |
| Operating Income | $936M-48.1% | $1.8B+58.9% | $1.1B+2.0% | $1.1B+33.0% |
| Net Income | $745M-12.2% | $849M-1.2% | $859M-2.8% | $884M+35.2% |
Columns use the calendar quarter of each reported period end date. QoQ is shown for adjacent company reporting quarters only.
AI Signal
Generated Aug 1, 2026
Finlify's signal for SYK is AVOID, with a Finlify Score of 31.4 out of 100, suggesting a generally unfavorable quantitative outlook for the asset at this time.
Technical
The asset's Relative Strength score of 19.3/100 indicates potential underperformance relative to other assets. While SYK has seen positive recent returns, with an 11.1% gain over 20 days and 19.7% over 60 days, it remains 10.2% below its 52-week high. The Accumulation / Volume score of 44.8/100 suggests moderate buying interest.
Fundamentals
The Fundamental Trend score of 14.2/100 appears quite low, indicating a potentially weak or deteriorating fundamental outlook. Valuation multiples, such as a P/E ratio of 38.4x, P/B of 6.0x, and P/S of 5.0x, may suggest the asset is trading at a premium. Despite this, the Financial Quality score of 61.1/100 indicates reasonable underlying financial health, and the asset offers a dividend yield of 1.01%.
Macro Context
The prevailing macro environment, characterized by elevated inflation (CPI YoY at 3.7%, Core PCE at 3.3%) and higher interest rates (10Y Treasury Yield at 4.7%), may present headwinds for growth-oriented assets like SYK, potentially impacting its valuation and future performance.
Key Risks
- The very low Fundamental Trend score of 14.2/100 suggests a concerning deterioration in underlying business performance or outlook.
- Elevated valuation multiples, including a P/E of 38.4x and P/B of 6.0x, may indicate limited upside or increased risk if growth expectations are not met.
- The recent earnings 'MISS' and the next earnings date being today (2026-07-30) could introduce significant volatility and further pressure on the stock.